Fouli GE, Gnudi L. The future: experimental therapies for renal disease in diabetes. Nephron. 2019;143:3–7.
Srivastava SP, Hedayat AF, Kanasaki K, Goodwin JE. microRNA crosstalk nfluences epithelial-to-mesenchymal, endothelial-to-mesenchymal, and macrophage-to-mesenchymal transitions in the kidney. Front Pharm. 2019;10:904–17.
Srivastava SP, Koya D, Kanasaki K. MicroRNAs in kidney fibrosis and diabetic nephropathy: roles on EMT and EndMT. Biomed Res Int. 2013;2013:125469.
Xu Y, Ouyang C, Lyu D, Lin Z, Zheng W, Xiao F, et al. Diabetic nephropathy execrates epithelial-to-mesenchymal transition (EMT) via miR-2467-3p/Twist1 pathway. Biomed Pharmacother. 2020;125:109920.
Hua W, Dijke PT, Kostidis S, Giera M, Hornsveld M. TGFβ-induced metabolic reprogramming during epithelial-to-mesenchymal transition in câncer. Cell Mol Life Sci. 2020;77:2103–23.
Pu J, Zhang Y, Zhou J. Effect of Huai Qi Huang on epithelial-mesenchymal transition of renal tubular epithelial cells through miR-200a. Evid Based Complement Altern Med. 2016;2016:8612190.
Caja L, Tan EJ. Epithelium to Mesenchyme Transition. In: Boffetta P, Hainaut P, eds. Encyclopedia of Cancer. 3rd Edition. New York: Tisch Cancer Institute; Grenoble: Institute for Advanced Biosciences. Academic Press of Elsevier; 2019. p. 14–23.
Xiong M, Jiang L, Zhou Y, Qiu W, Fang L, Tan R, et al. The miR-200 family regulates TGF-β1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression. Am J Physiol Ren Physiol. 2012;302:F369–79.
Sene LB, Mesquita FF, Moraes LN, Santos DC, Carvalho R, Gontijo JAR, et al. Involvement of Renal Corpuscle microRNA Expression on Epithelial-to-mesenchymal transition in maternal low protein diet in adult programmed rats. PLoS ONE. 2010;8:e71310.
Guo C, Dong G, Liang X, Dong Z. Epigenetic regulation in AKI and kidney repair: mechanisms and therapeutic implications. Nat Rev Nephrol. 2019;15:220–39.
Cavallari I, Ciccarese F, Sharova E, Urso L, Raimondi V, Silic-Benussi M, et al. The miR-200 family of microRNAs: fine tuners of epithelial-mesenchymal transition and circulating cancer biomarkers. Cancers (Basel). 2021;13:5874–907.
Hill L, Browne G, Tulchinsky E. ZEB/miR-200 feedback loop: at the crossroads of signal transduction in cancer. Int J Cancer. 2013;132:745–54.
Felício JS, Luz RM, Melo FTC, Resende FS, Oliveira AF, Peixoto AS, et al. Vitamin D on early stages of diabetic kidney disease: a cross-sectional study in patients with type 1 diabetes mellitus. Front Endocrinol (Lausanne). 2016;7:149.
Manucha W, Juncos LI. The protective role of vitamin D on the heart and the kidney. Ther Adv Cardiovasc Dis. 2017;11:12–19.
Thethi TK, Bajwa MA, Ghanim H, Jo C, Weir M, Goldfine AB, et al. Effect of paricalcitol on endothelial function and inflammation in type 2 diabetes and chronic kidney disease. J Diabetes Complications. 2015;29:433–7.
Hu X, Liu W, Yan Y, Liu H, Huang Q, Xiao Y, et al. Vitamin D protects against diabetic nephropathy: Evidence-based effectiveness and mechanism. Eur J Pharm. 2019;845:91–98.
Joergensen C, Hovind P, Schmedes A, Parving HH, Rossing P. Vitamin D levels, microvascular complications, and mortality in type 1 diabetes. Diabetes Care. 2011;34:1081–5.
Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993;123:1939–51.
Junod A, Lambert AE, Stauffacher W, Renold AE. Diabetogenic action of streptozotocin: relationship of dose to metabolic response. J Clin Invest. 1969;48:2129–39.
Veelken R, Hilgers KF, Hartner A, Haas A, Bohmer KP, Sterzel RB. Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy. J Am Soc Nephrol. 2000;11:71–9.
Rodrigues AM, Bergamaschi CT, Araújo RC, Mouro MG, Rosa TS, Higa EM. Effects of training and nitric oxide on diabetic nephropathy progression in type I diabetic rats. Exp Biol Med. 2011;236:1180–7.
Culshaw GJ, Costello HM, Binnie D, Stewart KR, Czopek A, Dhaun N, et al. Impaired pressure natriuresis and non‐dipping blood pressure in rats with early type 1 diabetes mellitus. J Physiol. 2019;597:767–80.
Derakhshanian H, Djazayery A, Javanbakht MH, Eshraghian MR, Mirshafiey A, Zarei M, et al. The effect of vitamin D on cellular pathways of diabetic nephropathy. Rep. Biochem Mol Biol. 2019;7:217–22.
Venkat P, Ning R, Zacharek A, Culmone L, Liang L, Landschoot‐Ward J, et al. Treatment with an Angiopoietin‐1 mimetic peptide promotes neurological recovery after stroke in diabetic rats. CNS Neurosci Ther. 2021;27:48–59.
Volpini RA, Giovanini C, Costa RS, Coimbra TM. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats. Diabetes Metab Res Rev. 2003;19:43–51.
Laurell CB. Electroimmuno assay. Scand J Clin Lab Investig. 1972;29:21–37.
Souza CS, Oliveira BSS, Viana GN, Correia TML, Bragança AC, Canale D, et al. Preventive effect of exercise training on diabetic kidney disease in ovariectomized rats with type 1 diabetes. Exp Biol Med. 2019;244:758–69.
Almeida LF, Francescato HDC, Antunes-Rodrigues J, de Paula FJA, Giovanni C, Costa RS, et al. Imbalance of pro- and anti-angiogenic factors due to maternal vitamin D deficiency causes renal microvasculature alterations affecting the adult kidney function. Nutrients. 2019;11:1929–44.
Andersen LB, Przybyl L, Haase N, Versen‐Höynck F, Qadri F, Jorgensen JS, et al. Vitamin D depletion aggravates hypertension and target‐organ damage. J Am Heart Assoc. 2015;4:e001417.
Darraj H, Badedi M, Poore KR, Hummadi A, Khawaji A, Solan Y, et al. Vitamin D deficiency and glycemic control among patients with type 2 diabetes mellitus in Jazan City, Saudi Arabia. Diabetes Metab Syndr Obes. 2019;12:853–62.
Bragança AC, Canale D, Gonçalves J, Shimizu MHM, Seguro AC, Volpini RA. Vitamin D deficiency aggravates the renal features of moderate chronic kidney disease in 5/6 nephrectomized rats. Front Med. 2018;5:282–97.
Zhang Y, Kong J, Deb DK, Chang A, Li YC. Vitamin D receptor attenuates renal fibrosis by suppressing the renin-angiotensin system. J Am Soc Nephrol. 2010;21:966–73.
Hu Z, Zhang H, Yi B, Yang S, Liu J, Hu J, et al. VDR activation attenuate cisplatin induced AKI by inhibiting ferroptosis. Cell Death Dis. 2020;11:1–11.
Li A, Yi B, Han H, Shikun Y, Hu Z, Zheng L, et al. Vitamin D-VDR (vitamin D receptor) regulates defective autophagy in renal tubular epithelial cell in streptozotocin-induced diabetic mice via the AMPK pathway. Autophagy. 2022;18:877–90.
Schiller A, Gadalean F, Schiller O, Timar R, Bob F, Munteanu M, et al. Vitamin D deficiency prognostic marker or mortality risk factor in end stage renal disease patients with diabetes mellitus treated with hemodialysis–a prospective multicenter study. PLoS ONE. 2015;10:e0126586.
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911–30.
Zhou T, Shen L, Li Z, Jia J, Xing H, Wang N, et al. Severe 25-hydroxyvitamin D deficiency may predict poor renal outcomes in patients with biopsy-proven diabetic nephropathy. Front Endocrinol (Lausanne). 2022;13:1–8.
Gonçalves JG, Bragança AC, Canale D, Shimizu MHM, Sanches TR, Moysés RMA, et al. Vitamin D deficiency aggravates chronic kidney disease progression after ischemic acute kidney injury. PLoS ONE. 2014;9:e107228.
Zhang X, Song Z, Guo Y, Zhou M. The novel role of TRPC6 in vitamin D ameliorating podocyte injury in STZ-induced diabetic rats. Mol Cell Biochem. 2015;399:155–65.
Chokhandre MK, Mahmoud MI, Hakami T, Jafer M, Inamdar AS. Vitamin D & its analogues in type 2 diabetic nephropathy: a systematic review. J Diabetes Metab Disord. 2015;14:58–68.
Mäkitaipale J, Sankari S, Sievänen H, Laitinen-Vapaavuori O. The relationship between serum 25-hydroxyvitamin D and parathyroid hormone concentration in assessing vitamin D deficiency in pet rabbits. BMC Vet Res. 2020;16:403–11.
Essawy M, Soylemezoglu O, Muchaneta-Kubara EC, Shortland J, Brown CB, Nahas AM. Myofibroblasts and the progression of diabetic nephropathy. Nephrol Dial Transpl. 1997;12:43–50.
Bernardo DRD, Canale D, Nascimento MM, Shimizu MHM, Seguro AC, Bragança AC, et al. The association between obesity and vitamin D deficiency modifies the progression of kidney disease after ischemia/reperfusion injury. Front Nutr. 2022;9:952028.
Song Z, Xiao C, Jia X, Luo C, Shi L, Xia R, et al. Vitamin D/VDR protects against diabetic kidney disease by restoring podocytes autophagy. Diabetes Metab Syndr Obes. 2021;14:1681–93.
Sánchez-Tilló E, Siles L, Cuatrecasas BOM, Vaquero EC, Castells A, et al. Expanding roles of ZEB factors in tumorigenesis and tumor progression. Am J Cancer Res. 2011;1:897–912.
Wei J, Zhang Y, Luo Y, Wang Z, Bi S, Song D, et al. Aldose reductase regulates miR-200a- 3p/141-3p to coordinate Keap1–Nrf2, Tgfβ1/2, andZeb1/2 signaling in renal mesangial cells and the renal cortex of diabetic mice. Free Radic Biol Med. 2014;67:91–102.
Tang O, Chen XM, Shen S, Hahn M, Pollock CA. MiRNA-200b represses transforming growth factor-β1-induced EMT and fibronectin expression in kidney proximal tubular cells. Am J Physiol Ren Physiol. 2013;304:F1266–73.
Jin HF, Wang JF, Song TT, Zhang J, Wang L. MiR-200b inhibits tumor growth and chemoresistance via targeting p70S6K1 in lung cancer. Front Oncol. 2020;10:643.
Zheng Q, Cui X, Zhang D, Yang Y, Yan X, Liu M, et al. miR-200b inhibits proliferation and metastasis of breast cancer by targeting fucosyltransferase IV and α1,3-fucosylated glycans. Oncogenesis. 2017;6:e358.
Li SR, Tan ZX, Chen YH, Hu B, Zhang C, Wang H, et al. Vitamin D deficiency exacerbates bleomycin-induced pulmonary fibrosis partially through aggravating TGF-β/ Smad2/3-mediated epithelial-mesenchymal transition. Respiratory Res. 2019;20:266–76.